0001104659-22-073634.txt : 20220622
0001104659-22-073634.hdr.sgml : 20220622
20220622202439
ACCESSION NUMBER: 0001104659-22-073634
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220622
FILED AS OF DATE: 20220622
DATE AS OF CHANGE: 20220622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manting Erik
CENTRAL INDEX KEY: 0001856180
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40363
FILM NUMBER: 221033362
MAIL ADDRESS:
STREET 1: C/O TRANSCODE THERAPEUTICS, INC.
STREET 2: 6 LIBERTY SQUARE, #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcode Therapeutics, Inc.
CENTRAL INDEX KEY: 0001829635
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811065054
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-301-6857
MAIL ADDRESS:
STREET 1: 6 LIBERTY SQUARE
STREET 2: #2382
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
tm2219203-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-22
0
0001829635
Transcode Therapeutics, Inc.
RNAZ
0001856180
Manting Erik
C/O TRANSCODE THERAPEUTICS, INC.
6 LIBERTY SQUARE, #2382
BOSTON
MA
02109
1
0
0
0
Stock Option (Right to Buy)
1.24
2022-06-22
4
A
0
9500
0
A
2032-06-21
Common Stock
9500
9500
D
The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.
/s/ Thomas A. Fitzgerald, as Attorney-in-Fact
2022-06-22